These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5856173)

  • 1. Disturbances of calcium metabolism in the cancer patient.
    Pearson OH
    Proc Natl Cancer Conf; 1964; 5():445-50. PubMed ID: 5856173
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of hydrochlorothiazide on various parameters of calcium and phosphate metabolism in patients with increased bone resorption caused by malignant metastases to the skeleton].
    Gasińska T; Rozek-Lesiak K; Harbut-Gryłka A
    Pol Tyg Lek; 1979 Sep; 34(38):1499-502. PubMed ID: 503956
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calcium and neoplasms. Effect of daunomycin. Hypercalcemia in neoplasms].
    Bossa R; Galatulas I
    G Ital Chemioter; 1975; 22(1-2):55-62. PubMed ID: 1235354
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary hydroxyproline and calcium metabolism in patients with cancer.
    Bonadonna G; Merlino MJ; Myers WP; Sonenberg M
    N Engl J Med; 1966 Aug; 275(6):298-305. PubMed ID: 5940693
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypercalcemia and hyperthyroidism; apropos of 3 cases].
    Arlet P; Carles P; Latorzeff S; Arlet J
    Rev Rhum Mal Osteoartic; 1974; 41(7):534-8. PubMed ID: 4279436
    [No Abstract]   [Full Text] [Related]  

  • 6. [Malignant neoplasms and calcium metabolism (a review of the literature)].
    Kashulina AP; Tereshchenko IP
    Patol Fiziol Eksp Ter; 1973; 17(5):84-8. PubMed ID: 4789470
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease.
    Tucci M; Mosca A; Lamanna G; Porpiglia F; Terzolo M; Vana F; Cracco C; Russo L; Gorzegno G; Tampellini M; Torta M; Reimondo G; Poggio M; Scarpa RM; Angeli A; Dogliotti L; Berruti A
    Prostate Cancer Prostatic Dis; 2009; 12(1):94-9. PubMed ID: 18332901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Statements on the role of the parathyroid glands in bone metastases].
    Less E
    Endokrinologie; 1966 Aug; 50(3):122-30. PubMed ID: 5998872
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of hypercalcemia of tumoral origin with two diphosphonates].
    Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
    Schweiz Med Wochenschr; 1980 Nov; 110(48):1822-4. PubMed ID: 6792698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcemia in patients with advanced mammary cancer and osseous metastases. Effect of hormone therapy and schedule of treatment.
    Donovan AJ; Bethune JE; Berne TV
    Am Surg; 1966 Oct; 32(10):673-80. PubMed ID: 5921429
    [No Abstract]   [Full Text] [Related]  

  • 11. DERANGEMENTS OF CALCIUM METABOLISM IN PATIENTS WITH NEOPLASTIC BONE INVOLVEMENT.
    SPENCER H; LEWIN I
    J Chronic Dis; 1963 Jul; 16():713-26. PubMed ID: 14047260
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of malignancy-associated hypercalcemia].
    Endo I; Inoue D
    Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-induced hypercalcemia.
    Coward DD
    Cancer Nurs; 1986 Jun; 9(3):125-32. PubMed ID: 3636175
    [No Abstract]   [Full Text] [Related]  

  • 14. [Aspects of phospho-calcic metabolism in the aged].
    Lo Bruno D; Tabarroni F; Rapino P; Vezzadini P; D'Avena A
    G Gerontol; 1968 Nov; 16(11):1201-26. PubMed ID: 5731970
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
    Chapuy MC; Meunier PJ; Alexandre CM; Vignon EP
    J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of osteolytic sterols in human breast cancer.
    Gordan GS; Fitzpatrick ME; Lubich WP
    Trans Assoc Am Physicians; 1967; 80():183-9. PubMed ID: 6082239
    [No Abstract]   [Full Text] [Related]  

  • 17. Mediators of bone resorption and hypercalcemia in cancer.
    Pugliese G
    N Engl J Med; 1988 Mar; 318(10):642-3. PubMed ID: 3344013
    [No Abstract]   [Full Text] [Related]  

  • 18. [Abnormal calcium-bone metabolism: current topics].
    Nihon Naika Gakkai Zasshi; 1993 Dec; 82(12):2038-52. PubMed ID: 8294804
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy.
    Kawada K; Minami H; Okabe K; Watanabe T; Inoue K; Sawamura M; Yagi Y; Sasaki T; Takashima S
    Jpn J Clin Oncol; 2005 Jan; 35(1):28-33. PubMed ID: 15681601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
    Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
    Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.